Themes US R&D Champions ETF Rating $33.64 -0.07 (-0.22%) As of 10/3/2025 Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestTrendsBuy This Stock Themes US R&D Champions ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.USRD Aggregate RatingModerate Buy 2.66Holdings in USRD have an aggregate rating of Moderate Buy based on 670 analyst ratings issued in the past year covering 25 companies (55.1% of the portfolio).USRD Aggregate Price Target$33.64High Prediction$33.64Average Prediction$33.64Low Prediction$33.64Holdings in USRD have an aggregate price target of $33.64 and a range of $33.64 to $33.64 covering 25 companies (55.1% of the portfolio).USRD Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Themes US R&D Champions ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 USRD Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.67%TSLATesla$429.83-1.4%4.1533 of 5 stars2.36$343.43 -20.1%42Trending NewsAnalyst ForecastAnalyst Revision2.65%GOOGLAlphabet$245.35-0.1%3.7053 of 5 stars2.87$240.76 -1.9%47Trending NewsAnalyst ForecastInsider Trade2.64%LRCXLam Research$145.81-0.8%4.5126 of 5 stars2.74$119.20 -18.2%31Positive NewsAnalyst Upgrade2.32%ANETArista Networks$145.51+0.7%4.8003 of 5 stars2.86$162.00 11.3%22Positive NewsInsider Trade2.32%AVGOBroadcom$338.37+0.1%4.9406 of 5 stars3.06$357.22 5.6%34Trending NewsAnalyst Forecast2.32%ORCLOracle$286.23-0.9%4.7874 of 5 stars2.69$304.71 6.5%39Trending NewsInsider Trade2.29%ZMZoom Communications$80.96-1.6%4.5205 of 5 stars2.48$91.74 13.3%29Analyst Upgrade2.27%QCOMQUALCOMM$169.18+0.2%4.8017 of 5 stars2.52$182.82 8.1%25Positive NewsInsider Trade2.26%AAPLApple$258.02+0.3%4.6129 of 5 stars2.58$247.49 -4.1%33Trending NewsAnalyst UpgradeInsider TradeAnalyst Revision2.25%EAElectronic Arts$200.69-0.2%4.1583 of 5 stars2.16$177.00 -11.8%31Trending NewsAnalyst ForecastInsider Trade2.16%REGNRegeneron Pharmaceuticals$600.004.7545 of 5 stars2.79$817.67 36.3%29Positive NewsAnalyst Revision2.15%KEYSKeysight Technologies$173.35-1.0%4.5112 of 5 stars2.78$187.38 8.1%9Positive News2.14%MSIMotorola Solutions$453.47+1.2%4.9177 of 5 stars2.75$513.78 13.3%12Positive News2.11%AMATApplied Materials$217.53-2.7%4.524 of 5 stars2.52$195.12 -10.3%31Trending NewsAnalyst Forecast2.10%ADSKAutodesk$318.90-0.6%4.6751 of 5 stars2.80$359.13 12.6%25Positive NewsAnalyst UpgradeInsider Trade2.07%JNJJohnson & Johnson$188.51+1.4%4.7094 of 5 stars2.68$188.88 0.2%22Trending NewsAnalyst Forecast2.07%AXONAxon Enterprise$715.51-0.7%3.5938 of 5 stars2.78$841.64 17.6%18Positive NewsInsider Trade2.06%LLYEli Lilly and Company$840.46+2.5%4.9907 of 5 stars2.64$938.94 11.7%25Trending NewsAnalyst ForecastOptions Volume2.05%GEHCGE HealthCare Technologies$76.56-0.3%3.8121 of 5 stars2.64$86.89 13.5%112.05%ARMARM$152.64+0.3%3.5727 of 5 stars2.70$168.52 10.4%272.04%IBMInternational Business Machines$288.62+0.7%4.4346 of 5 stars2.47$284.62 -1.4%17Positive News2.03%METAMeta Platforms$710.56-2.3%4.4854 of 5 stars2.98$830.02 16.8%48Trending NewsInsider Trade2.03%CSCOCisco Systems$67.92-0.6%4.9513 of 5 stars2.64$74.53 9.7%25Positive News2.02%ADBEAdobe$346.74-1.3%4.8576 of 5 stars2.43$433.41 25.0%28Trending News2.00%ZTSZoetis$146.450.0%4.8683 of 5 stars2.50$200.88 37.2%10Positive News This page (NASDAQ:USRD) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Themes US R&D Champions ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Themes US R&D Champions ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
